Systematic review / meta-analysis / 2007
Calcium intake was not linked to lower hip fracture risk, and trials showed no reduction with supplementation.
Cohort analyses of 170,991 women (pooled RR per 300 mg/d: 1.01; 95% CI: 0.97, 1.05) and 68,606 men (pooled RR per 300 mg/d: 0.92; 95% CI: 0.82, 1.03) showed calcium intake was not significantly associated with hip fracture risk. In 4 clinical trials with 6,504 subjects, the pooled RR for hip fracture between calcium and placebo was 1.64 (95% CI: 1.02, 2.64), leading authors to conclude that trials show no reduction in hip fracture risk and an increased risk is possible. For nonvertebral fractures across 5 trials, calcium supplementation had a neutral effect (RR 0.92; 95% CI: 0.81, 1.05).
- Study type
- Meta-analysis of prospective cohorts and randomized controlled trials
- Who was studied
- 239,597 adults in cohort studies and 6,740 participants in randomized trials
- What was measured
- Hip fracture and nonvertebral fracture risk
THE PAPER
Calcium intake and hip fracture risk in men and women: a meta-analysis of prospective cohort studies and randomized controlled trials.
Bischoff-Ferrari HA, Dawson-Hughes B, Baron JA, Burckhardt P, Li R, Spiegelman D, Specker B, Orav JE, Wong JB, Staehelin HB, O'Reilly E, Kiel DP, Willett WC. Am J Clin Nutr, 2007.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.